IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ARICI, Bruna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.210
EU - Europa 2.144
AS - Asia 1.746
SA - Sud America 335
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 7
AN - Antartide 1
Totale 6.493
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.141
CN - Cina 659
DE - Germania 630
SG - Singapore 547
PL - Polonia 347
UA - Ucraina 346
BR - Brasile 274
IT - Italia 202
FI - Finlandia 146
HK - Hong Kong 125
FR - Francia 120
IN - India 120
VN - Vietnam 112
RU - Federazione Russa 105
GB - Regno Unito 98
TR - Turchia 61
IE - Irlanda 50
CA - Canada 35
SE - Svezia 33
MX - Messico 27
BD - Bangladesh 25
AR - Argentina 22
BE - Belgio 20
ID - Indonesia 16
EC - Ecuador 13
EU - Europa 13
IQ - Iraq 12
JP - Giappone 10
NL - Olanda 10
PK - Pakistan 10
ZA - Sudafrica 10
ES - Italia 8
AU - Australia 7
PY - Paraguay 7
SA - Arabia Saudita 6
AT - Austria 5
CO - Colombia 5
CZ - Repubblica Ceca 5
IR - Iran 5
KE - Kenya 5
EG - Egitto 4
JO - Giordania 4
NG - Nigeria 4
RO - Romania 4
RS - Serbia 4
TH - Thailandia 4
UY - Uruguay 4
AZ - Azerbaigian 3
BH - Bahrain 3
CL - Cile 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
MU - Mauritius 3
MY - Malesia 3
PE - Perù 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BG - Bulgaria 2
DZ - Algeria 2
IL - Israele 2
JM - Giamaica 2
OM - Oman 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
LB - Libano 1
LK - Sri Lanka 1
MN - Mongolia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SD - Sudan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 6.493
Salva come PNG Salva come JPEG
Città #
Warsaw 347
Singapore 299
Jacksonville 239
Ashburn 167
Beijing 140
Hong Kong 122
Chandler 115
Fairfield 114
Woodbridge 105
Ann Arbor 102
The Dalles 98
Nanjing 96
Princeton 96
Helsinki 93
New York 82
Wilmington 81
Houston 76
Cambridge 62
San Jose 54
Los Angeles 50
Dearborn 49
Dublin 49
Istanbul 45
Lauterbourg 43
Seattle 43
Brescia 37
Ho Chi Minh City 37
Nanchang 35
Munich 34
Buffalo 27
Shenyang 27
Changsha 24
Des Moines 24
São Paulo 24
Tianjin 24
Hebei 22
Jinan 20
Milan 20
Orem 19
San Francisco 18
Brussels 17
Hanoi 16
Pune 16
Jiaxing 15
Toronto 15
Moscow 14
Shanghai 13
Dong Ket 12
Lancaster 12
Dallas 11
Guangzhou 11
Hangzhou 11
Kocaeli 11
Kunming 11
Mexico City 11
North York 10
Chicago 9
Falkenstein 9
Nürnberg 9
Redondo Beach 9
Rio de Janeiro 9
San Diego 9
Atlanta 8
Santa Clara 8
Verona 8
Brooklyn 7
Dhaka 7
Mumbai 7
Ningbo 7
Tokyo 7
Belo Horizonte 6
Chennai 6
Jakarta 6
Johannesburg 6
Rome 6
Turku 6
Zhengzhou 6
Amsterdam 5
Baghdad 5
Boardman 5
Council Bluffs 5
Da Nang 5
Frankfurt am Main 5
Guayaquil 5
Haikou 5
Nuremberg 5
Phoenix 5
Poplar 5
Taizhou 5
Asunción 4
Cairo 4
Campinas 4
Charlotte 4
Curitiba 4
Denver 4
Hefei 4
Juiz de Fora 4
London 4
Melbourne 4
Montreal 4
Totale 3.624
Salva come PNG Salva come JPEG
Nome #
Sorafenib induces variations of the DNA methylome in HA22T/VGH human hepatocellular carcinoma-derived cells 320
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells. 264
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma 259
Effects of miR-193a and sorafenib on hepatocellular carcinoma cells. 230
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 223
MicroRNAs as Biomarkers of hepatocellular carcinoma and molecular targeted therapeutics with sorafenib 183
Preparazione di colture primarie di fibroblasti di embrione di pollo . 182
microRNAs and human hepatocellular carcinoma 179
LASP1 directly interacts with vimentin and its expression stratifies patients affected by human hepatocellular carcinoma 172
miR24, MiR 27a e miR193a nell'HCC: potenzialità prognostiche e terapeutiche. 166
MicroRNA 193a negatively regulates urokinase and in combination with sorafenib impairs the aggressive properties of HCC cells 164
miR-193a sensitizes hepatocellular carcinoma cells to sorafenib and impairs their aggressive properties. 152
In vitro c-met inhibition by antisense RNA and plasmid -based RNAi down modulates migration and invasion of hepatocellular carcinoma cells. 149
Antisense u-PA mRNA strategy inhibits the proliferation and invasion of human hepatocellular carcinoma cells. 146
The combined use of miR-193a and sorafenib displays in vitro anticancer effects in hepatocellular carcinoma. 138
"Trasformazione indotta dai virus oncogeni ad RNA. Tecniche di produzione e titolazione del RSV in colture di fibroblasti di embrione di pollo" pp. 27- 34, settembre 1987, in: , CLEUP-Padova, Italia. 135
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. 132
Urokinase and c-met are target of miR-23b in human cells. 130
Characterization and development of miRNA-like shRNA for urokinase targeting in human hepatocellular carcinoma 126
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma. 125
Espressione stabile di siRNA per il gene urochinasi nell'epatocarcinoma cellulare 123
MicroRNA ed Epatocarcinoma: il microRNA-23b media la downmodulazione di urochinasi e c-met e la capacità di migrazione di cellule derivate da HCC 120
Il silenziamento di urochinasi in cellule tumorali epatiche determina la downmodulazione di Lasp-1 118
Downregulation of urokinase by antisense and RNAi strategies inhibits the proliferation and migration of human hepatocellular carcinoma cells. 118
Urokinase targeting in human hepatocellular carcinoma by shRNAs/miR-23b and proteomic identification of LASP1 as uPA effector. 117
Specific downregulation of urokinase by stable expression of antisense u-PA mRNA and u-PA siRNA inhibits proliferation, invasion,and migration of human hepatocellular carcinoma. 115
RNA interference against urokinase in hepatocellular carcinoma xenografts in nude mice. 114
MicroRNA-23b mediates urokinase and MET downmodulation and inhibits migration of human hepatocellular carcinoma cells. 113
L'espressione stabile di RNA antisenso e di siRNA per u-PA inibisce la proliferazione , la migrazione e l'invasione di cellule di epatocarcinoma umano. 112
Tecniche di conservazione delle cellule mediante congelamento. 112
L'espressione stabile della sequenza antisenso dell'mRNA dell'u-PA inibisce la proliferazione e l'invasione di cellule di epatocarcinoma umano. 111
MicroRNA-23b negatively regulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 110
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 109
Il microRNA-23b media la downmodulazione di urochinasi e met ed inibisce la migrazione di cellule umane derivate da epatocarcinoma cellulare. 108
MicroRNA-23b downmodulates urokinase and c-met and inhibits migration of human hepatocellular carcinoma cells. 108
MET silencing in human hepatocellular carcinoma: antisense and RNA interference 107
miR-23b down-regulates urokinase and c-met expression and inhibits migration of human hepatocellular carcinoma cells. 104
miR-23b regulates uPA and c-met expression and mediates inhibition of HCC cells migration and proliferation. 104
L'espressione stabile di siRNA per il gene urochinasi diminuisce la capacità invasiva e di migrazione di cellule di epatocarcinoma cellulare umano. 99
Targeted therapy for human hepatocellular carcinoma (HCC): RNA interference for urokinase targeting in HCC xenografts in nude mice 99
RNA interference per il gene urochinasi nell'epatocarcinoma cellulare umano 99
RNA interference for urokinase gene in human hepatocellular carcinoma 96
RNA interference for urokinase targeting limits growth of hepatocellular carcinoma xenografts in nude mice 94
Stable expression of siRNA for urokinase gene in human hepatocellular carcinoma 93
Molecular therapies for hepatocellular carcinoma: silencing of urokinase by antisense and siRNA stable u-PA expression. 93
Strategie ablative per il silenziamento genico di c-met nell'epatocarcinoma cellulare umano: tecnologia antisenso ed RNAi. 92
Profilo proteomico di cellule umane tumorali epatiche dopo silenziamento genico di urochinasi mediante RNAi 91
Molecular therapies for hepatocellular carcinoma: silencing of urokinase-type plasminogen activator by antisense and siRNA stable u-PA expression 87
The down-modulation of miR-23b in hepatocellular carcinoma is mediated by DNA methylation 45
Totale 6.586
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.743
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.743
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022356 9 66 10 26 2 9 10 23 17 35 50 99
2022/2023339 61 13 13 32 31 88 0 24 45 2 15 15
2023/2024361 20 12 28 10 26 90 36 7 72 6 4 50
2024/2025849 2 19 4 117 83 114 44 15 117 33 162 139
2025/20261.576 174 234 131 241 166 111 208 58 90 124 33 6
2026/202730 30 0 0 0 0 0 0 0 0 0 0 0
Totale 6.586